不动杆菌肺炎：综述
Acinetobacter pneumonia: a review.
作者信息
Hartzell Joshua D, Kim Andrew S, Kortepeter Mark G, Moran Kimberly A
机构信息
Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
出版信息
MedGenMed. 2007 Jul 5;9(3):4.
Abstract
Acinetobacter species are becoming a major cause of nosocomial infections, including hospital-acquired and ventilator-associated pneumonia. Acinetobacter species have become increasingly resistant to antibiotics over the past several years and currently present a significant challenge in treating these infections. Physicians now rely on older agents, such as polymyxins (colistin), for treatment. This paper reviews the epidemiology, treatment, and prevention of this emerging pathogen.
摘要
不动杆菌属正成为医院感染的主要原因，包括医院获得性肺炎和呼吸机相关性肺炎。在过去几年中，不动杆菌属对抗生素的耐药性日益增强，目前在治疗这些感染方面构成了重大挑战。医生现在依靠较老的药物，如多粘菌素（黏菌素）进行治疗。本文综述了这种新出现病原体的流行病学、治疗和预防。
相似文献
1
Acinetobacter pneumonia: a review.不动杆菌肺炎：综述
MedGenMed. 2007 Jul 5;9(3):4.
2
[Nosocomial pneumonia due to Acinetobacter baumannii].[鲍曼不动杆菌所致医院获得性肺炎]
Enferm Infecc Microbiol Clin. 2005 Dec;23 Suppl 3:46-51. doi: 10.1157/13091220.
3
Nosocomial Acinetobacter pneumonia.医院获得性不动杆菌肺炎
Respirology. 2007 Nov;12(6):787-91. doi: 10.1111/j.1440-1843.2007.01147.x.
4
Nosocomial ventilator-associated pneumonia in Cuban intensive care units: bacterial species and antibiotic resistance.古巴重症监护病房医院获得性呼吸机相关性肺炎：细菌种类和抗生素耐药性。
MEDICC Rev. 2013 Apr;15(2):26-9. doi: 10.37757/MR2013V15.N2.6.
5
A case of Acinetobacter calcoaceticus pneumonia.一株醋酸钙不动杆菌肺炎病例。
Thorax. 1995 Mar;50(3):315-6; discussion 317-8. doi: 10.1136/thx.50.3.315.
6
[Nosocomial pneumonia caused by multiresistant Acinetobacter baumanii treated by colistin and rifampicin].[多粘菌素和利福平治疗多重耐药鲍曼不动杆菌引起的医院获得性肺炎]
Ann Fr Anesth Reanim. 2006 May;25(5):543-4. doi: 10.1016/j.annfar.2006.01.006. Epub 2006 Feb 20.
7
How should we treat acinetobacter pneumonia?我们应该如何治疗不动杆菌肺炎？
Curr Opin Crit Care. 2019 Oct;25(5):465-472. doi: 10.1097/MCC.0000000000000649.
8
Novel therapies for treatment of multi-drug resistant Acinetobacter baumannii skin infections.治疗多重耐药鲍曼不动杆菌皮肤感染的新疗法。
Virulence. 2011 Mar-Apr;2(2):97-102. doi: 10.4161/viru.2.2.15061. Epub 2011 Mar 1.
9
[Multidrug-resistant Acinetobacter baumannii infection in respiratory intensive care unit].[呼吸重症监护病房的多重耐药鲍曼不动杆菌感染]
Mikrobiyol Bul. 2009 Oct;43(4):575-85.
10
Antimicrobial susceptibility pattern in nosocomial infections caused by Acinetobacter species in Asir Region, Saudi Arabia.
Pak J Biol Sci. 2013 Mar 15;16(6):275-80. doi: 10.3923/pjbs.2013.275.280.
引用本文的文献
1
Rapid Molecular Diagnostics of Pneumonia Caused by Gram-Negative Bacteria: A Clinician's Review.革兰氏阴性菌引起的肺炎的快速分子诊断：临床医生综述
Antibiotics (Basel). 2024 Aug 25;13(9):805. doi: 10.3390/antibiotics13090805.
2
A fulminant presentation of post-COVID-19 necrotizing pneumonia and ischemic stroke in an 8-year-old girl: A case report and literature review.一名8岁女孩新冠肺炎后暴发性坏死性肺炎和缺血性卒中的病例报告及文献复习
Clin Case Rep. 2024 Jul 28;12(8):e9222. doi: 10.1002/ccr3.9222. eCollection 2024 Aug.
3
Bacteria in the oral cavity of individuals consuming intoxicating substances.食用致醉物质个体口腔中的细菌。
PLoS One. 2023 May 26;18(5):e0285753. doi: 10.1371/journal.pone.0285753. eCollection 2023.
4
Identification and prioritization of potential therapeutic molecules against LpxA from - A computational study.针对LpxA的潜在治疗性分子的鉴定与优先级排序——一项计算研究
Curr Res Struct Biol. 2023 Feb 15;5:100096. doi: 10.1016/j.crstbi.2023.100096. eCollection 2023.
5
Investigation of microorganisms in cannabis after heating in a commercial vaporizer.研究商用蒸发器加热大麻后微生物的变化。
Front Cell Infect Microbiol. 2023 Jan 13;12:1051272. doi: 10.3389/fcimb.2022.1051272. eCollection 2022.
6
Droperidol as a potential inhibitor of acyl-homoserine lactone synthase from A. baumannii: insights from virtual screening, MD simulations and MM/PBSA calculations.鲍曼不动杆菌酰高丝氨酸内酯合酶的虚拟筛选、分子动力学模拟和 MM/PBSA 计算研究发现，氟哌利多可能是其抑制剂。
Mol Divers. 2023 Oct;27(5):1979-1999. doi: 10.1007/s11030-022-10533-2. Epub 2022 Oct 3.
7
Gearing up for battle: Harnessing adaptive T cell immunity against gram-negative pneumonia.备战：利用适应性 T 细胞免疫对抗革兰氏阴性肺炎。
Front Cell Infect Microbiol. 2022 Aug 18;12:934671. doi: 10.3389/fcimb.2022.934671. eCollection 2022.
8
Global Meta-analysis of Airborne Bacterial Communities and Associations with Anthropogenic Activities.全球大气细菌群落及其与人为活动相关性的荟萃分析。
Environ Sci Technol. 2022 Jul 19;56(14):9891-9902. doi: 10.1021/acs.est.1c07923. Epub 2022 Jul 4.
9
Alert Germ Infections: Chest X-ray and CT Findings in Hospitalized Patients Affected by Multidrug-Resistant Pneumonia.警惕真菌感染：住院多重耐药性肺炎患者的胸部 X 光和 CT 表现。
Tomography. 2022 Jun 14;8(3):1534-1543. doi: 10.3390/tomography8030126.
10
Virulence Characteristics of Biofilm-Forming in Clinical Isolates Using a Model.使用模型研究临床分离株中生物膜形成的毒力特征。
Microorganisms. 2021 Nov 16;9(11):2365. doi: 10.3390/microorganisms9112365.
本文引用的文献
1
Aerosolized tobramycin in the treatment of ventilator-associated pneumonia: a pilot study.雾化吸入妥布霉素治疗呼吸机相关性肺炎：一项初步研究。
Surg Infect (Larchmt). 2007 Feb;8(1):73-82. doi: 10.1089/sur.2006.051.
2
Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization.多重耐药鲍曼不动杆菌感染的死亡率和住院时间。
Emerg Infect Dis. 2007 Jan;13(1):97-103. doi: 10.3201/eid1301.060716.
3
Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections.多粘菌素单药治疗与多粘菌素-美罗培南联合治疗对多重耐药革兰氏阴性菌感染的有效性及肾毒性
Clin Microbiol Infect. 2006 Dec;12(12):1227-30. doi: 10.1111/j.1469-0691.2006.01559.x.
4
Susceptibility of acinetobacter strains isolated from deployed U.S. military personnel.从部署的美国军事人员中分离出的不动杆菌菌株的易感性。
Antimicrob Agents Chemother. 2007 Jan;51(1):376-8. doi: 10.1128/AAC.00858-06. Epub 2006 Oct 16.
5
Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center.对从沃尔特里德陆军医疗中心接受治疗的军事和 civilian 患者中分离出的多重耐药不动杆菌属菌株中的抗生素耐药基因进行分析。
注：这里“civilian”常见释义为“平民”“民用的”等，结合语境这里可能是指非军事人员的患者，翻译为“ civilian”更合适，但如果有更准确的背景信息，可能有更精准的译法。
Antimicrob Agents Chemother. 2006 Dec;50(12):4114-23. doi: 10.1128/AAC.00778-06. Epub 2006 Sep 25.
6
Impact of Acinetobacter infection on the mortality of burn patients.不动杆菌感染对烧伤患者死亡率的影响。
J Am Coll Surg. 2006 Oct;203(4):546-50. doi: 10.1016/j.jamcollsurg.2006.06.013. Epub 2006 Aug 24.
7
Population pharmacokinetic analysis and dosing regimen optimization of meropenem in adult patients.美罗培南在成年患者中的群体药代动力学分析及给药方案优化
J Clin Pharmacol. 2006 Oct;46(10):1171-8. doi: 10.1177/0091270006291035.
8
Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria.静脉注射多粘菌素治疗仅对多粘菌素敏感（POS）革兰氏阴性菌感染患者的有效性和肾毒性。
Eur J Clin Microbiol Infect Dis. 2006 Sep;25(9):596-9. doi: 10.1007/s10096-006-0191-2.
9
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections.黏菌素：用于多重耐药革兰氏阴性菌感染的再度兴起的抗生素。
Lancet Infect Dis. 2006 Sep;6(9):589-601. doi: 10.1016/S1473-3099(06)70580-1.
10
Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections.利福平/亚胺培南联合用药治疗耐碳青霉烯类鲍曼不动杆菌感染
J Antimicrob Chemother. 2006 Sep;58(3):697-700. doi: 10.1093/jac/dkl274.
Zotero 插件